Beyondspring Inc is a biotechnology company focused on the development of innovative therapies for cancer treatment. The company specializes in immuno-oncology, with a particular emphasis on leveraging the power of the immune system to combat tumors. BeyondSpring aims to enhance the effectiveness of current cancer therapies while minimizing side effects, ultimately improving the quality of life for patients. Through rigorous research and clinical trials, the company is dedicated to bringing novel treatment options to market and addressing unmet needs in the oncology space. Read More
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.
Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.
Credit Suisse boosted the price target for KBR, Inc. (NYSE: KBR) from $68 to $71. Credit Suisse analyst Jamie Cook maintained an Outperform rating. KBR shares rose 4.4% to close at $59.16 on Monday.
Gainers SeqLL Inc. (NASDAQ: SQL) shares jumped 120% to $1.85 after dropping around 39% on Thursday. SeqLL recently announced the establishment of a two-year Cooperative Research and Development Agreement with the U.S. Department of Justice's Federal Bureau of Investigation.
